| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $11K | — | +175.0% |
| Cost of Revenue | $126K | — | — |
| Gross Profit | -$115K | — | -2975.0% |
| R&D Expense | $3.5M | — | +6.2% |
| SG&A Expense | $2.3M | — | +11.7% |
| Operating Income | -$6.3M | — | -15.8% |
| Net Income | -$6.1M | — | -16.6% |
| EPS (Basic) | -$0.17 | — | +0.0% |
| EPS (Diluted) | -$0.17 | — | +0.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $14.2M | -26.3% | -41.3% |
| Short-term Investments | $26.9M | — | — |
| Accounts Receivable | $41K | — | — |
| Current Assets | $42.1M | +114.6% | +71.4% |
| Total Assets | $43.6M | +106.8% | +66.2% |
| Current Liabilities | $2.2M | +8.8% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$4.6M | — | +3.7% |
| Capital Expenditures | $0 | — | -100.0% |
| Investing Cash Flow | -$27.0M | — | -2809.6% |
| Financing Cash Flow | $26.5M | — | +1145.7% |
| Free Cash Flow | -$4.6M | — | +3.7% |
| -23.8% |
| Total Liabilities | $3.1M | +13.2% | +3.4% |
| Stockholders' Equity | $40.5M | +120.6% | +74.2% |